CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
12.6233
0.16%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.5834
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Gohealth Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 12.6033
Open* 12.6033
1-Year Change* -21.17%
Day's Range* 12.5433 - 12.6633
52 wk Range 7.05-22.85
Average Volume (10 days) 13.99K
Average Volume (3 months) 373.69K
Market Cap 265.99M
P/E Ratio -100.00K
Shares Outstanding 22.37M
Revenue 527.35M
EPS -13.62
Dividend (Yield %) N/A
Beta 1.80
Next Earnings Date Mar 14, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 26, 2024 12.6233 0.0200 0.16% 12.6033 12.8833 12.4733
Feb 23, 2024 12.4733 -0.3900 -3.03% 12.8633 12.8633 12.4733
Feb 22, 2024 12.5533 -0.1500 -1.18% 12.7033 12.9333 12.5133
Feb 21, 2024 12.4233 -0.1600 -1.27% 12.5833 12.8533 12.3733
Feb 20, 2024 12.8833 -0.1200 -0.92% 13.0033 13.4133 12.8533
Feb 16, 2024 13.4833 0.2300 1.74% 13.2533 13.7733 13.2533
Feb 15, 2024 13.4733 0.4800 3.69% 12.9933 13.8633 12.9233
Feb 14, 2024 12.7133 0.2100 1.68% 12.5033 12.9033 12.4133
Feb 13, 2024 12.3333 -0.5300 -4.12% 12.8633 12.9933 12.2533
Feb 12, 2024 13.1333 0.6200 4.95% 12.5133 13.5233 12.5133
Feb 9, 2024 12.5433 0.8200 6.99% 11.7233 12.8233 11.7233
Feb 8, 2024 11.9833 0.1600 1.35% 11.8233 12.2633 11.8233
Feb 7, 2024 11.7833 -0.4200 -3.44% 12.2033 12.2033 11.7833
Feb 6, 2024 11.9933 0.3300 2.83% 11.6633 12.1433 11.5333
Feb 5, 2024 11.4833 -0.1800 -1.54% 11.6633 11.7033 11.4833
Feb 2, 2024 11.9233 0.2400 2.05% 11.6833 12.1333 11.6833
Feb 1, 2024 11.8633 0.5300 4.68% 11.3333 12.2333 11.2533
Jan 31, 2024 11.5133 -0.5100 -4.24% 12.0233 12.0233 11.5133
Jan 30, 2024 11.8233 -0.2800 -2.31% 12.1033 12.5033 11.8233
Jan 29, 2024 12.2633 -0.1400 -1.13% 12.4033 12.5033 12.2033

GoHealth, Inc. Events

Time (UTC) Country Event
Thursday, March 14, 2024

Time (UTC)

20:00

Country

US

Event

Q4 2023 Gohealth Inc Earnings Release
Q4 2023 Gohealth Inc Earnings Release

Forecast

-

Previous

-
Monday, May 6, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Gohealth Inc Earnings Release
Q1 2024 Gohealth Inc Earnings Release

Forecast

-

Previous

-
Wednesday, May 22, 2024

Time (UTC)

14:00

Country

US

Event

Gohealth Inc Annual Shareholders Meeting
Gohealth Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 631.675 1062.42 877.35 539.501 226.205
Revenue 631.675 1062.42 877.35 539.501 226.205
Cost of Revenue, Total 187.67 239.335 199.202 169.553 79.582
Gross Profit 444.005 823.08 678.148 369.948 146.623
Total Operating Expense 950.341 1563.8 941.896 572.278 197.442
Selling/General/Admin. Expenses, Total 329.231 470.874 449.777 182.618 55.587
Depreciation / Amortization 94.057 94.056 94.056 28.217 0
Unusual Expense (Income) 37.529 398.488 8.512 0
Other Operating Expenses, Total 301.854 361.044 198.861 183.378 62.273
Operating Income -318.666 -501.382 -64.546 -32.777 28.763
Interest Income (Expense), Net Non-Operating -57.069 -33.505 -32.969 -8.216 -0.224
Other, Net 0.115 0.669 0.358 -0.097 -0.379
Net Income Before Taxes -375.62 -534.218 -97.157 -41.09 28.16
Net Income After Taxes -376.384 -534.194 -97.2 -41.068 28.114
Minority Interest 227.678 344.837 52.933 0 0.003
Net Income Before Extra. Items -148.706 -189.357 -44.267 -41.068 28.117
Net Income -148.706 -189.357 -44.267 -41.068 28.117
Income Available to Common Excl. Extra. Items -148.706 -189.357 -18.802 -41.068 28.117
Income Available to Common Incl. Extra. Items -148.706 -189.357 -18.802 -41.068 28.117
Diluted Net Income -148.706 -189.357 -18.802 -41.068 28.117
Diluted Weighted Average Shares 8.445 7.06607 5.6126 15.8626 0.55767
Diluted EPS Excluding Extraordinary Items -17.6088 -26.7981 -3.34996 -2.58899 50.419
Diluted Normalized EPS -14.1954 9.87497 -3.26473 -2.20061 50.9901
Total Adjustments to Net Income 0 25.465
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 142.779 183.158 69.376 133.052 158.654
Revenue 142.779 183.158 69.376 133.052 158.654
Cost of Revenue, Total 36.422 45.462 20.629 48.044 51.074
Gross Profit 106.357 137.696 48.747 85.008 107.58
Total Operating Expense 195.795 188.907 202.554 192.191 259.695
Selling/General/Admin. Expenses, Total 78.77 69.732 82.478 49.894 84.071
Depreciation / Amortization 23.515 23.514 23.514 23.514 23.515
Other Operating Expenses, Total 54.401 50.199 75.621 60.592 76.04
Operating Income -53.016 -5.749 -133.178 -59.139 -101.041
Interest Income (Expense), Net Non-Operating -17.265 -16.891 -17.317 -15.63 -12.724
Other, Net -0.021 0.053 0.05 0.115 0.013
Net Income Before Taxes -70.302 -22.587 -150.445 -74.654 -113.752
Net Income After Taxes -70.229 -22.543 -150.737 -74.654 -113.752
Minority Interest 41.287 13.364 89.338 44.649 69.933
Net Income Before Extra. Items -28.942 -9.179 -61.399 -30.005 -43.819
Net Income -28.942 -9.179 -61.399 -30.005 -43.819
Income Available to Common Excl. Extra. Items -28.942 -9.179 -61.399 -30.005 -43.819
Income Available to Common Incl. Extra. Items -28.942 -9.179 -61.399 -30.005 -43.819
Diluted Net Income -28.942 -9.179 -61.399 -30.005 -43.819
Diluted Weighted Average Shares 9.122 8.965 8.8998 8.8252 8.296
Diluted EPS Excluding Extraordinary Items -3.17277 -1.02387 -6.89892 -3.39992 -5.28194
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.9374 -0.9062 -6.5929 -2.25015 -1.83221
Unusual Expense (Income) 2.687 0.312 10.147 24.995
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 414.556 428.995 391.822 143.769 54.028
Cash and Short Term Investments 16.464 84.361 144.234 12.276 0.505
Cash & Equivalents 16.464 84.361 144.234 12.276 0.505
Total Receivables, Net 340.499 285.939 218.394 125.539 48.54
Accounts Receivable - Trade, Net 4.703 17.276 26.871 24.461 9.855
Prepaid Expenses 57.593 58.695 29.194 5.954 4.983
Total Assets 1659.29 2068.85 2108.8 1602.3 142.837
Property/Plant/Equipment, Total - Net 46.765 47.735 17.353 6.339 11.782
Property/Plant/Equipment, Total - Gross 65.026 58.061 22.369 6.86 31.804
Accumulated Depreciation, Total -18.261 -10.326 -5.016 -0.521 -20.022
Goodwill, Net 0 386.553 386.553 0
Intangibles, Net 500.611 594.669 688.726 782.783 0
Note Receivable - Long Term 695.637 993.844 622.27 281.853 76.842
Other Long Term Assets, Total 1.721 3.608 2.072 0.998 0.185
Total Current Liabilities 265.455 217.067 127.371 113.065 47.984
Accounts Payable 15.148 39.843 8.733 13.582 10.534
Accrued Expenses 62.308 58.914 26.926 22.568 9.72
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.27 5.373 4.17 3 4.856
Other Current Liabilities, Total 182.729 112.937 87.542 73.915 22.874
Total Liabilities 1341.23 1715.75 1728.38 742.151 83.49
Total Long Term Debt 504.81 665.115 396.4 288.654 0.152
Long Term Debt 504.81 665.115 396.4 288.233 0
Capital Lease Obligations 0.421 0.152
Deferred Income Tax 0.243 0.254
Other Liabilities, Total 297.324 294.179 185.87 340.189 35.1
Total Equity 318.061 353.103 380.416 860.144 59.347
Preferred Stock - Non Redeemable, Net -1.598 547.542 0
Common Stock 0.002 0.032 0.032 312.619 248.435
Retained Earnings (Accumulated Deficit) -357.023 -208.317 -18.802 0 -189.102
Other Equity, Total -0.144 -0.059 0.017 -0.017 0.014
Total Liabilities & Shareholders’ Equity 1659.29 2068.85 2108.8 1602.3 142.837
Total Common Shares Outstanding 22.004 21.3893 21.4129 20.9055 20.9055
Minority Interest 273.64 539.387 1018.74
Additional Paid-In Capital 626.269 561.447 399.169
Redeemable Preferred Stock 50.9
Treasury Stock - Common -0.345
Total Preferred Shares Outstanding 0.05
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 346.32 368.098 375.461 414.556 468.147
Cash and Short Term Investments 26.387 25.364 32.325 16.464 215.403
Cash & Equivalents 26.387 25.364 32.325 16.464 215.403
Total Receivables, Net 298.334 330.303 319.124 340.499 222.772
Accounts Receivable - Trade, Net 12.412 35.984 26.181 4.703 4.835
Prepaid Expenses 21.599 12.431 24.012 57.593 29.972
Total Assets 1437.41 1482.25 1543.45 1659.29 2001.68
Property/Plant/Equipment, Total - Net 48.282 41.085 45.254 46.765 48.366
Goodwill, Net
Intangibles, Net 430.069 453.583 477.097 500.611 524.126
Note Receivable - Long Term 609.831 617.243 643.861 695.637 959.105
Other Long Term Assets, Total 2.907 2.243 1.781 1.721 1.932
Total Current Liabilities 217.775 210.258 209.81 265.455 255.421
Accounts Payable 6.213 8.704 11.409 15.148 9.37
Accrued Expenses 52.442 56.567 38.297 62.308 41.697
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 19.289 5.27 5.27
Other Current Liabilities, Total 159.12 144.987 140.815 182.729 199.084
Total Liabilities 1160.18 1183.04 1230.64 1341.23 1628.31
Total Long Term Debt 496.965 496.224 490.214 504.81 660.387
Long Term Debt 496.965 496.224 490.214 504.81 660.387
Minority Interest 176.682 210.845 259.784 273.64 364.294
Other Liabilities, Total 268.754 265.709 270.829 297.324 348.204
Total Equity 277.233 299.216 312.817 318.061 373.37
Common Stock 0.002 0.002 0.002 0.002 0.033
Additional Paid-In Capital 649.47 646.232 630.316 626.269 621.118
Retained Earnings (Accumulated Deficit) -419.054 -395.144 -366.202 -357.023 -295.691
Other Equity, Total -0.064 -0.125 -0.142 -0.144 -0.171
Total Liabilities & Shareholders’ Equity 1437.41 1482.25 1543.45 1659.29 2001.68
Total Common Shares Outstanding 22.367 22.236 22.036 22.004 21.9637
Treasury Stock - Common -2.423 -1.051 -0.459 -0.345 -0.345
Preferred Stock - Non Redeemable, Net -1.598 -1.598 -1.598 -1.598 -1.674
Redeemable Preferred Stock 50.9 50.9 50.9 50.9 50.1
Total Preferred Shares Outstanding 0.05 0.05 0.05 0.05 0.05
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -376.384 -534.194 -97.2 -41.068 28.114
Cash From Operating Activities 60.904 -299.006 -114.217 -0.003 5.443
Cash From Operating Activities 12.945 13.451 4.496 4.768 6.16
Amortization 94.057 94.056 94.056 28.217 0
Non-Cash Items 60.126 434.097 236.668 159.247 0.791
Cash Taxes Paid 0.486 0.879 0.286 0.177 0.032
Cash Interest Paid 56.92 28.244 32.671 5.577 0.219
Changes in Working Capital 270.16 -306.416 -352.237 -151.167 -29.622
Cash From Investing Activities -13.512 -19.801 -14.523 -815.607 -6.17
Capital Expenditures -13.512 -19.801 -14.523 -8.016 -6.17
Other Investing Cash Flow Items, Total -807.591 0
Cash From Financing Activities -115.051 259.089 260.663 827.43 0.063
Financing Cash Flow Items -4.683 -6.623 -714.573 -9.283 -0.079
Issuance (Retirement) of Stock, Net 50.005 0 862.407 541.263 0
Issuance (Retirement) of Debt, Net -160.373 265.712 112.829 295.45 0.142
Foreign Exchange Effects -0.238 -0.155 0.035 -0.049 -0.003
Net Change in Cash -67.897 -59.873 131.958 11.771 -0.667
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -22.543 -376.384 -225.647 -150.993 -37.241
Cash From Operating Activities 20.479 60.904 101.903 6.377 54.486
Cash From Operating Activities 2.753 12.945 9.881 5.33 2.434
Amortization 23.514 94.057 70.543 47.029 23.514
Non-Cash Items 6.162 60.126 54.807 46.56 7.2
Changes in Working Capital 10.593 270.16 192.319 58.451 58.579
Cash From Investing Activities -2.226 -13.512 -12.096 -9.658 -5.997
Capital Expenditures -2.226 -13.512 -12.096 -9.658 -5.997
Cash From Financing Activities -2.397 -115.051 41.54 -4.463 -3.105
Financing Cash Flow Items -0.114 -4.683 -4.404 -1.725 -1.725
Issuance (Retirement) of Stock, Net 50.005 50
Issuance (Retirement) of Debt, Net -1.391 -160.373 -4.056 -2.738 -1.38
Foreign Exchange Effects 0.005 -0.238 -0.305 -0.461 -0.117
Net Change in Cash 15.861 -67.897 131.042 -8.205 45.267
Total Cash Dividends Paid -0.892
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Centerbridge Partners, L.P. Private Equity 43.9436 4179850 0 2023-08-24
Kotte (Vijay) Individual Investor 5.8 551686 7241 2023-05-15 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.4956 237381 178734 2023-06-30 LOW
Corient Private Wealth LLC Investment Advisor 2.1339 202974 202974 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0763 197495 19373 2023-06-30 LOW
Schulz (Jason) Individual Investor 1.8245 173548 6881 2023-05-15 MED
Hargis (Mike) Individual Investor 1.7522 166666 166666 2023-09-29
Eversept Partners, LP Hedge Fund 1.102 104820 -20233 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9554 90881 41333 2023-06-30 LOW
Blue Owl Capital Holdings LP Investment Advisor 0.8754 83264 -1 2023-06-30 MED
Glendon Capital Management L.P. Investment Advisor/Hedge Fund 0.7565 71961 0 2023-06-30 LOW
Farley (Brian P) Individual Investor 0.7369 70089 -226 2023-07-15 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.7262 69073 48277 2023-06-30 LOW
Fisher (David A.) Individual Investor 0.6913 65754 13137 2023-05-23 LOW
NVX Holdings, Inc. Corporation 0.5658 53820 0 2023-08-24
Cruz (Shane E) Individual Investor 0.5 47559 5113 2023-04-25 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.3647 34694 -16111 2023-06-30 LOW
Flanagan (Joseph Gerard) Individual Investor 0.3547 33739 13137 2023-05-23 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.3271 31118 31118 2023-06-30 LOW
Citadel Advisors LLC Hedge Fund 0.3037 28885 28885 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GoHealth, Inc. Company profile

GoHealth, Inc. operates a health insurance marketplace to enhance access to healthcare in the United States. The company, through its platform, offer various health insurance policies, including Medicare advantage, Medicare supplement, Medicare prescription drug plans, and Medicare special needs plans; and individual and family, dental, vision, and other related plans. The company was founded in 2001 and is headquartered in Chicago, Illinois.
Industry: Insurance Brokers

214 West Huron Street
CHICAGO
ILLINOIS 60654
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Gold

2,032.76 Price
-0.160% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

77.45 Price
+1.140% 1D Chg, %
Long position overnight fee 0.0052%
Short position overnight fee -0.0272%
Overnight fee time 22:00 (UTC)
Spread 0.040

BTC/USD

56,462.45 Price
+9.020% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

17,903.70 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading